Yu Feng - Concepedia

Author

Yu Feng

Chinese University of Hong Kong ORCID

Also Known As

Yu Feng, Yu-Mei Feng, Yu-mei Feng, Zhou, Jingying

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Chinese University of Hong Kong University of Hong Kong Shanghai Jiao Tong University Sun Yat-sen University Nanyang Technological University

About

Yu Feng is an author at Chinese University of Hong Kong specializing in tumor microenvironment, medicine, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	135
2	Cell Biology	2	2	135
3	Immunology	2	2	135
4	Health Sciences	1	1	91
5	Pathology	1	1	91

Yu Feng

Publications

Citations

H-Index

Page 1

	Year	Citations
Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy Jingying Zhou, Man Liu, Hanyong Sun, Gut	2017	197
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma Man Liu, Jingying Zhou, Xiaoyu Liu, Gut	2019	170
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma Weiqin Yang, Yu Feng, Jingying Zhou, Science Translational Medicine	2021	148
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver Wenshu Tang, Jingying Zhou, Weiqin Yang, Cellular and Molecular Immunology T-regulatory CellImmunologyPathologyCell DeathImpairs Antitumor Immunosurveillance	2022	91
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma Hanyong Sun, Weiqin Yang, Yuan Tian, Nature Communications	2018	89
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma Zhewen Xiong, Stephen L. Chan, Jingying Zhou, Gut	2023	89
Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients Yu Feng, Wenjuan Ma, Yupeng Zang, Nature Communications	2024	45
Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis Xuezhen Zeng, Jingying Zhou, Zhewen Xiong, Cellular and Molecular Immunology Hepatocellular CarcinomaMedicineLiver PhysiologyImmunologyBiological Microenvironments	2020	44
The IL‐21‐TET2‐AIM2‐c‐MAF pathway drives the T follicular helper cell response in lupus‐like disease Haijing Wu, Yaxiong Deng, Di Long, Clinical and Translational Medicine	2022	44
A network pharmacology-based study on the anti-hepatoma effect of Radix Salviae Miltiorrhizae Yi Luo, Yu Feng, Lei Song, Chinese Medicine	2019	43

Page 1